Keyphrases
Chemotherapy
100%
Phase II Study
100%
Tumor Ablation
100%
Metastatic Sarcoma
100%
Ablation Therapy
42%
Ablation
28%
Stable Disease
28%
Progression-free
28%
Histology
14%
Randomized Trial
14%
Window of Opportunity
14%
Median Overall Survival
14%
Median Progression-free Survival
14%
Disease-free Survival
14%
Metastatic Disease
14%
Patient Selection
14%
Lessons Learned
14%
Surveillance Imaging
14%
Effective Approach
14%
Interventional Radiology
14%
Lung Metastasis
14%
Residual Disease
14%
Accruals
14%
Studying up
14%
Rhabdomyosarcoma
14%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
14%
Leiomyosarcoma
14%
Off Therapy
14%
Myxoid Liposarcoma
14%
Metastatic Deposit
14%
Systemic Control
14%
Treatment-free Interval
14%
Progression-free Interval
14%
Medicine and Dentistry
Progression Free Survival
100%
Tumor Ablation
100%
Connective Tissue Cancer
100%
Ablation Therapy
75%
Diseases
50%
Metastatic Carcinoma
25%
Overall Survival
25%
Prospective Study
25%
Disease Free Survival
25%
Rhabdomyosarcoma
25%
Lung Metastasis
25%
Minimal Residual Disease
25%
Interventional Radiology
25%
Malignant Peripheral Nerve Sheath Tumor
25%
Leiomyosarcoma
25%
Myxosarcoma
25%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Chemotherapy
100%
Connective Tissue Cancer
100%
Progression Free Survival
57%
Diseases
28%
Prospective Study
14%
Overall Survival
14%
Disease Free Survival
14%
Metastasis
14%
Minimal Residual Disease
14%
Lung Metastasis
14%
Malignant Peripheral Nerve Sheath Tumor
14%
Leiomyosarcoma
14%
Rhabdomyosarcoma
14%
Myxosarcoma
14%